A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/1999
11/18/1999	WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999	WO1999042584A9 Apoptosis inducing molecule ii and methods of use
11/18/1999	WO1999037682A3 Antibodies against human il-12
11/18/1999	WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999	DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999	CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999	CA2331631A1 Benzocarbazoles and indenoindoles as estrogenic agents
11/18/1999	CA2331371A1 Water-soluble pro-drugs of propofol
11/18/1999	CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999	CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999	CA2328062A1 Secreted proteins and polynucleotides encoding them
11/17/1999	EP0956862A1 Methods of increasing lean tissue mass using ob protein compositions
11/17/1999	EP0956040A1 Stimulation of host defense mechanisms against viral challenges
11/17/1999	EP0955808A1 Human g-protein coupled receptor
11/17/1999	EP0572537B1 Cytokine inhibitors
11/17/1999	CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999	CN1235033A Medicine for osteodynia due to pathogenic wind-dampness
11/16/1999	US5985905 Useful for the treatment and/or prophylaxis of diseases associated with loss of bone mass, such as osteoporosis and related osteopenic diseases, paget's disease, hyperparathyroidism and related diseases, also antitumor
11/16/1999	US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999	US5985897 Benzothiphene compounds, intermediates, compositions, and methods
11/16/1999	US5985881 Treatment and prevention of respiratory disorders, inflammatory eye diseases, inflammatory skin diseases, intestinal disorders, other inflammatory diseases
11/16/1999	US5985849 Phosphate compounds and their use as medicaments
11/16/1999	US5985832 Inhibiting osteoclastogenesis by administering osteoclast inhibitor protein (oip) to a cell
11/16/1999	US5985335 Potassium citrate, malate or lactate; vitamin d, calcium salt and vitamin k; bone disorders, osteoporosis treatment; foods; dietetics
11/11/1999	WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999	WO1999057274A1 Human protease associated proteins
11/11/1999	WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999	WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999	WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999	WO1999056785A2 Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction
11/11/1999	WO1999056784A2 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
11/11/1999	WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999	WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999	WO1999047677A3 Polypeptides homologous to vegf and bmp1
11/11/1999	WO1999047132A3 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
11/11/1999	WO1999045031A9 Cd147 binding molecules as therapeutics
11/11/1999	WO1999040083A3 Bifunctional tryptase inhibitors
11/11/1999	WO1999040073A3 Tryptase inhibitors
11/11/1999	CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999	CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999	CA2329704A1 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
11/11/1999	CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999	CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/11/1999	CA2327263A1 Human protease associated proteins
11/11/1999	CA2295510A1 Use of a nuclease inhibitor or interleukin-10 (il-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy
11/11/1999	CA2248963A1 Novel compounds
11/10/1999	EP0955286A1 Dihydro- or tetrahydronaphthalene derivatives having (anti-)estrogen activity
11/10/1999	EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999	EP0954580A1 Human sdf-5 protein and compositions
11/10/1999	EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999	EP0954532A1 Novel human apoptosis regulator
11/10/1999	EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999	EP0954323A1 Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
11/10/1999	EP0954317A2 Use of 7 apha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
11/10/1999	EP0954302A1 Therapeutic methods and compositions involving isoflavones
11/10/1999	EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999	CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999	CN1234396A Process for alkylation of hindered sulfamide
11/10/1999	CN1234235A Chinese medicine capsule for treating lumbar and cervical protrusion
11/09/1999	US5981780 In vivo calcium transport as well as bone calcium mobilization activity, treatment of osteoporosis, possible use in the treatment of cancerous diseases
11/09/1999	US5981599 Inorganic ion receptor active compounds
11/09/1999	US5981574 Phenanthrofuran derivatives
11/09/1999	US5981570 Benzothiophene compounds, compositions, and methods
11/09/1999	US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999	US5981516 Treating cholesterol without estrogenic activity at the uterine level in women comprising administering to women an amount of a steroid
11/09/1999	US5981490 Peptidyl compounds
11/09/1999	US5981478 Integrin-binding peptides
11/09/1999	US5981222 Mammalian polynucleotide encoding protein factor; for disease prevention and treatment
11/04/1999	WO1999055898A1 Enzymatic resolvation for obtaining a (-)-3,4-trans-diarylchroman
11/04/1999	WO1999055859A2 Cd40-interacting and traf-interacting proteins
11/04/1999	WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999	WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999	WO1999055696A1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
11/04/1999	WO1999055663A1 Inhibitors of impdh enzyme
11/04/1999	WO1999055353A2 Protein formulations
11/04/1999	WO1999055335A1 Substituted tricyclic pyrazole derivatives with protein kinase activity
11/04/1999	WO1999055321A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999	DE19812204A1 Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung The use of extracts from Cimicifuga racemosa and Belamcanda sinensis estrogenartiges organ-selective drugs without a uterotrophic effect
11/04/1999	CA2329709A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999	CA2327504A1 Cd40-interacting and traf-interacting proteins
11/03/1999	EP0953576A1 Active hedgehog protein conjugate, process for its production and use
11/03/1999	EP0952975A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
11/03/1999	EP0952851A1 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices
11/03/1999	EP0763055B1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
11/03/1999	CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999	CN1234031A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF)
11/03/1999	CN1233964A Anti-carious chewing gums, candies, gels, toothpaste and dentifrices
11/03/1999	CN1233616A Active hedgehog protein conjugate, process for its prodn. and use
11/03/1999	CN1233468A Pharmaceutical composition comprising bisphosphonic acid
11/02/1999	US5977374 5-(4-hydroxy-OR 4-acetoxy-benzyl)-3- triphenylmethylthiazolidine-2,4-dione and method for producing same
11/02/1999	US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999	US5977178 Compounds with growth hormone releasing properties
11/02/1999	US5977173 Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
11/02/1999	US5977125 Mono-or polyenic carboxylic acid derivatives
11/02/1999	US5977103 Substituted imidazole compounds
11/02/1999	US5977084 Self-assembling polynucleotide delivery method
11/02/1999	US5977070 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
11/02/1999	US5976849 Human E3 ubiquitin protein ligase
11/02/1999	US5976838 Secreted proteins and polynucleotides encoding them
11/02/1999	US5976837 Secreted proteins and polynucleotides encoding them

1 ... 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 ... 820